Pharma In The New Health Economy: Pressures From Accelerating Market Trends
Health care reforms aimed at reducing medical costs will affect pharmaceutical companies more rapidly and in different ways than expected, thanks to accelerated changes by payors and providers. The three big trends that will reshape the health care market, and what pharmas need to do to counterbalance their effect.
You may also be interested in...
The End Of Drug Innovation In Diabetes?
Lacking revolutionary new treatment mechanisms in type 2 diabetes, pharma is relying on combinations, convenience, and beyond-the-pill services. As prices are squeezed, the winners will be those who can deliver the best-value outcomes, not necessarily those with a best-in-class drug.
Managing Pharma's Competing Challenges In The New Health Economy
The shifts roiling the health care industry are creating an entirely new commercial landscape. PwC says that the way pharma companies opt to address three pivotal challenges – patient engagement, analytics and value – will affect not only their future, but the future direction of patient care, provider decisions and payment mechanisms.